Answers are grounded in this paper and cite their sources.
Narrative review uncovers advances in molecular endotypes and targeted therapies in atopic dermatitis, highlighting a transformation in precision diagnostic and therapeutic strategies.
Atopic dermatitis is the most common chronic inflammatory skin condition. This review highlights most recent advances in understanding and treating this debilitating disease. We summarize new insights regarding molecular endotypes and clinical phenotypes that characterize atopic dermatitis, the role of the skin microbiome, and improvements in diagnostic tools. We also emphasize recent scientific advancements in understanding the mechanisms driving atopic dermatitis pathogenesis and discuss the identification and implementation of new targeted treatment approaches that have revolutionized therapeutic options for affected patients.
No takes yet. Share an insight, caveat, or question.
Meledathu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: